WS
VTVT icon

Wedbush Securities’s vTv Therapeutics VTVT Stock Holding History

Wedbush Securities’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-550
Closed -$39K – 978
2020
Q3 		$39K Buy
550
+35
+7% +$3.08K ﹤0.01% 898
2020
Q2 		$46K Buy
515
+150
+41% +$14.8K ﹤0.01% 910
2020
Q1 		$28K Buy
+365
New +$35.1K ﹤0.01% 849
2019
Q4 		– Sell
-628
Closed -$39K – 1034
2019
Q3 		$39K Buy
+628
New +$35.5K ﹤0.01% 952
2019
Q2 		– Sell
-438
Closed -$30K – 1033
2019
Q1 		$30K Buy
+438
New +$42.5K ﹤0.01% 912

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAG
Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

Wedbush Securities's VTVT Position: Q4 2020 in Review

Wedbush Securities sold out of vTv Therapeutics (VTVT) in Q4 2020, closing a stake of 550 shares — an estimated $39K sold.

Wedbush Securities first reported a position in VTVT in Q1 2019 and held it in 5 quarters. The position peaked at $46K in Q2 2020. 44 funds tracked by Wall St. Rank hold VTVT as of Q4 2020.

  • Wedbush Securities reported no remaining vTv Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 550 vTv Therapeutics shares in Q4 2020, an estimated $39K.
  • Wedbush Securities first reported a position in vTv Therapeutics in Q1 2019 and held it in 5 quarters.
  • Wedbush Securities's vTv Therapeutics position peaked at $46K in Q2 2020.
  • 44 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.